Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in SKYE — Skye Bioscience, Inc.

CIK 1423053 MIAMI, FL
Back to SKYE Full portfolio

Position in SKYE

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record

Common Shares in SKYE Over Time

Shares Held

Position Value (USD)

Derivatives in SKYE

reported options exposure · as of Jun 30, 2026
CallValue
$7,678
CallShares
11,075
PutValue
$3,067
PutShares
4,425

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,151,065,112 across 436 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in SKYE

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,067 35,400
2026-06-30 $7,678 88,600
2026-03-31 $3,003 39,100
2026-03-31 $4,594 59,800
2025-12-31 $6,063 64,700
2025-12-31 $1,686 18,000
2025-09-30 $13,853 28,200
2025-09-30 $14,173 28,852
2025-06-30 $17,451 33,400
2025-06-30 $8,725 16,700
2024-12-31 $88,442 250,014
2024-12-31 $35 100
2024-09-30 $7,429 15,200
2024-09-30 $3,958 8,100
2024-09-30 $122,193 250,013
2024-06-30 $1,101 1,100
2024-06-30 $265,918 265,587
2024-06-30 $1,101 1,100